Capture-Seq™: Compelling proof-of-concept clinical data. A world first in isolating pure tumor-derived DNA from a liquid biopsy

Capture-Seq™ is a breakthrough liquid biopsy technology delivering a world-first ability to isolate highly pure tumor-derived DNA from blood. With compelling clinical data showing exceptional accuracy across multiple cancers, it has the potential to transform early detection, treatment decisions, and patient outcomes.